American Joint Committee on Cancer staging system does not accurately predict survival in patients receiving multimodality therapy for esophageal adenocarcinoma Academic Article uri icon

Overview

MeSH Major

  • Adenocarcinoma
  • Esophageal Neoplasms
  • Neoplasm Staging

abstract

  • The current AJCC staging system is not a good predictor of survival after CRT. Although patients with a pCR do have improved long-term survival relative to patients with residual disease, this method places too much emphasis on residual depth of invasion and fails to identify patients with residual disease who have good long-term survival. Recursive partitioning analysis more accurately identifies nodal disease and metastatic disease as the most important prognostic variables. Degree of treatment response is less prognostic than nodal involvement.

publication date

  • February 10, 2007

Research

keywords

  • Academic Article

Identity

Language

  • eng

Digital Object Identifier (DOI)

  • 10.1200/JCO.2006.08.0101

PubMed ID

  • 17290058

Additional Document Info

start page

  • 507

end page

  • 12

volume

  • 25

number

  • 5